{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:04:05Z","timestamp":1786118645382,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"s1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1111\/j.1524-4725.2006.32331.x","type":"journal-article","created":{"date-parts":[[2007,1,3]],"date-time":"2007-01-03T10:43:04Z","timestamp":1167820984000},"page":"S44-S50","source":"Crossref","is-referenced-by-count":54,"title":["A Double\u2010Blind, Randomized, Comparative Study of Two Type A Botulinum Toxins in the Treatment of Primary Axillary Hyperhidrosis"],"prefix":"10.1097","volume":"33","author":[{"given":"S\u00c9RGIO","family":"TALARICO\u2010FILHO","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MAUR\u00cdCIO","family":"MENDON\u00c7A DO NASCIMENTO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FERNANDO","family":"SPERANDEO DE MACEDO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CARLA","family":"DE SANCTIS PECORA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20231117","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0190-9622(99)70258-6","article-title":"Side\u2010controlled intradermal injection of botulinum toxin A in recalcitrant axillary hyperhidrosis","volume":"41","author":"Heckman","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"R2-8-20231117","first-page":"394","article-title":"Autonomic neurodermatology (Part II)","volume":"12","author":"Freeman","year":"1992","journal-title":"disorders of sweating and flushing"},{"key":"R3-8-20231117","first-page":"511","article-title":"Efficacy of botulinum toxin in the treatment of axillary and palmar hyperhidrosis","volume":"130","author":"Maillard","year":"2003","journal-title":"10 cases"},{"key":"R4-8-20231117","first-page":"276","article-title":"Botulinum toxin","volume":"21","author":"Buchara","year":"1996","journal-title":"a possible new treatment for axillary hyperhidrosis"},{"key":"R6-8-20231117","first-page":"S11","article-title":"Botulinum neurotoxin serotype A","volume":"61","author":"Charles","year":"2004","journal-title":"a clinical update on non-cosmetic uses"},{"key":"R7-8-20231117","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1046\/j.1365-2133.1997.d01-1233.x","article-title":"Double\u2010blind trial of botulinum A toxin for treatment of focal hyperhidrosis of palms","volume":"135","author":"Schnider","year":"1997","journal-title":"Br J Dermatol"},{"key":"R8-8-20231117","first-page":"596","article-title":"Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis","volume":"15","author":"Naumann","year":"2001","journal-title":"randomised, parallel group, double blind, placebo controlled trial"},{"key":"R9-8-20231117","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1365-2133.1999.02769.x","article-title":"A randomized, double\u2010blind, placebo\u2010controlled trial of botulinum A toxin for severe axillary hyperhidrosis","volume":"140","author":"Schnider","year":"1999","journal-title":"Br J Dermatol"},{"key":"R10-8-20231117","first-page":"480","article-title":"Long\u2010term quantitative benefits of botulinum toxin type A in the treatment of axillary hyperhidrosis","volume":"28","author":"Odderson","year":"2002","journal-title":"Dermatol Surg"},{"key":"R11-8-20231117","first-page":"731","article-title":"Botulinum toxin type A is a safe and effective treatment for axillary hyperhidrosis over 16 months","volume":"139","author":"Naumann","year":"2003","journal-title":"a prospective study"},{"key":"R12-8-20231117","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJM200102153440704","article-title":"Botulinum toxin A for axillary hyperhidrosis (excessive sweating)","volume":"15","author":"Heckmann","year":"2001","journal-title":"N Engl J Med"},{"key":"R13-8-20231117","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1365-2133.2003.05620.x","article-title":"A double\u2010blind, randomized, comparative study of Dysport vs. Botox in primary palmar hyperhidrosis","volume":"149","author":"Simonetta Moreau","year":"2003","journal-title":"Br J Dermatol"},{"key":"R14-8-20231117","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2165\/00002512-200118040-00003","article-title":"Botulinum toxin A treatment of adult upper and lower limb spasticity","volume":"18","author":"Hesse","year":"2001","journal-title":"Drugs Aging"},{"key":"R15-8-20231117","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/jnnp.64.1.6","article-title":"A double blind, randomized, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia","volume":"64","author":"Odergren","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R16-8-20231117","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/jnnp.59.1.102","article-title":"Dose standardization of botulinum toxin","volume":"59","author":"Marion","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R17-8-20231117","first-page":"56","article-title":"Comparison of dosage effects between the American and British botulinum toxin A product in the treatment of spasmodic dysphonia","volume":"10","author":"Whurr","year":"1995","journal-title":"Mov Disord"},{"key":"R18-8-20231117","first-page":"459","article-title":"Respective potencies of Botox and Dysport","volume":"72","author":"Ranoux","year":"2002","journal-title":"a double blind, randomized, crossover study in cervical dystonia"},{"key":"R19-8-20231117","first-page":"1216","article-title":"Botulinum toxin type A for facial rejuvenation","volume":"24","author":"Lowe","year":"1998","journal-title":"United States and United Kingdom perspectives"},{"key":"R20-8-20231117","first-page":"1013","article-title":"DYSBOT","volume":"12","author":"Sampaio","year":"1997","journal-title":"a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A\u2014Dysport and Botox\u2014assuming a ratio of 4:1"},{"key":"R21-8-20231117","first-page":"545","article-title":"Botulinum toxin type A in the treatment of bilateral primary axillary hyperhidrosis","volume":"29","author":"Lowe","year":"2003","journal-title":"efficacy and duration with repeated treatments"},{"key":"R22-8-20231117","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1046\/j.1365-2133.2001.04349.x","article-title":"Treatment of focal hyperhidrosis with botulinum toxin type A. long\u2010term follow\u2010up in 61 patients","volume":"145","author":"Schnider","year":"2001","journal-title":"Br J Dermatol"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00042728-200701001-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:21:36Z","timestamp":1786033296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00042728-200701001-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":21,"journal-issue":{"issue":"s1","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1524-4725.2006.32331.x","relation":{},"ISSN":["1076-0512"],"issn-type":[{"value":"1076-0512","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}